Ryan White HIV/AIDS Program Implementation Program for HIV Clinical Quality Improvement | HRSA 20 071

Opportunity Information: Apply for HRSA 20 071

The Ryan White HIV/AIDS Program (RWHAP) Implementation Program for HIV Clinical Quality Improvement is a HRSA cooperative agreement designed to strengthen how RWHAP-funded organizations carry out clinical quality improvement in HIV care. The central goal is to provide training and technical assistance (T/TA) to RWHAP recipients and subrecipients so they can consistently use recognized quality improvement approaches, such as the Model for Improvement, Lean, and Lean Six Sigma, to improve patient care processes, patient health outcomes, and patient satisfaction. While clinical quality management (CQM) also includes infrastructure and performance measurement, this opportunity emphasizes practical quality improvement work that leads to measurable changes in real-world service delivery. All support provided through the project must align with the Ryan White HIV/AIDS Treatment Extension Act of 2009 and HRSA's Clinical Quality Management Policy Clarification Notice 15-02 (CQM PCN 15-02).

A major expectation of the program is that the awardee will help HIV service organizations identify where care is falling short and then guide them through closing those gaps using structured improvement methods. That includes helping sites define problems using data, select measures, test changes, implement improvement activities, and then assess whether those activities actually produced better results for patients. The intent is not simply to provide general education, but to promote adoption and routine use of quality improvement tools and techniques so that organizations become more effective at running improvement projects on their own over time.

The work plan described in the announcement includes several required activity areas. First, the awardee must offer quality improvement T/TA that is directly tied to improvement methodologies, tools, and techniques. This includes developing new and innovative trainings, creating and distributing practical tools and guides, delivering targeted and time-limited technical assistance to support specific improvement efforts, and running learning collaboratives that allow multiple sites to learn and improve together. Second, the awardee must evaluate the impact of the T/TA using scientifically accepted methods, monitor how efficiently and effectively recipients and subrecipients are implementing improvement activities, and then use evaluation findings to refine and adjust the assistance being provided. Third, the program requires the use of HRSA-developed or HRSA-approved performance measures and alignment with current HHS HIV clinical guidelines, such as the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, so that improvement work is grounded in up-to-date clinical standards and consistent measurement.

The opportunity also has strong dissemination and field-building expectations. The awardee is expected to participate in the National Ryan White Conference on HIV Care and Treatment by submitting presentation abstracts and sharing relevant information with the Ryan White community, with HRSA providing input and approval for proposed abstracts and presentations. In addition, all quality improvement T/TA materials, products, findings, best practices, and lessons learned must be posted and shared through the TargetHIV website to reach national and local audiences. Finally, the awardee must respond to HRSA requests for data and information related to project activities, reflecting the cooperative agreement structure where HRSA has an ongoing role in oversight and direction.

From an administrative standpoint, the funding opportunity is listed as HRSA-20-071 under the U.S. Department of Health and Human Services, Health Resources and Services Administration. It is a discretionary award using a cooperative agreement funding instrument, under CFDA 93.145. The announcement anticipated a single award, with an award ceiling of $1,500,000. The notice was created December 9, 2019, with an original application closing date of February 18, 2020, and eligibility described broadly as "Others" with additional eligibility details referenced in the full notice. Overall, the program is structured to build consistent, guideline-aligned quality improvement capacity across Ryan White-funded providers by combining hands-on technical assistance, evaluation-driven refinement, and broad dissemination of proven tools and lessons learned.

• The Department of Health and Human Services, Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Ryan White HIV/AIDS Program Implementation Program for HIV Clinical Quality Improvement" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.145.
• This funding opportunity was created on Dec 09, 2019.
• Applicants must submit their applications by Feb 18, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for HRSA 20 071

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: